Nuix (ASX:NXL) FY25 Results: ACV Rises 8% as Nuix Neo Surges 132%

Sonal Goyal

25 August 2025 02:34 PM AEST

Nuix (ASX:NXL) FY25 Results: ACV Rises 8% as Nuix Neo Surges 132%

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

NXL's annualised Contract Value (ACV) increased 8% year-on-year to AUD 228.4 million.

Cash EBITDA rose 24.5% to AUD 37.2 million, with a margin improvement to 16.8%.

Nuix Neo Annualised Contract Value surged 132% to AUD 28.1 million, adding 52 new customers.

Nuix Limited (ASX:NXL) today (25 August 2025) announced its financial results for the year ended 30 June 2025, reporting growth in Annualised Contract Value (ACV) and Cash EBITDA, underpinned by an increase in Nuix Neo adoption.

Financial Performance

Nuix reported an ACV of AUD 228.4 million as at 30 June 2025, representing an 8% rise from the prior year. Growth was achieved across all regions, with North America up 8.0%, EMEA up 8.4% and Asia Pacific up 7.5%. In constant currency terms, ACV increased by 6.9%.

Revenue was broadly stable at AUD 221.5 million, up 0.4% year-on-year. Cash EBITDA rose 24.5% to AUD 37.2 million, reflecting tighter cost control and lower variable pay. The Cash EBITDA margin improved to 16.8%, compared with 13.6% a year earlier.

Statutory EBITDA declined 14.8% to AUD 47.6 million, driven by higher Research and Development expenditure, elevated non-operational legal costs of AUD 10.6 million, and restructuring charges. Nuix recorded a statutory net loss after tax of AUD 9.2 million, compared to a net profit of AUD 5.0 million in the previous year.

Cash Flow and Balance Sheet

Nuix achieved positive underlying and overall cash flow during the year. Underlying cash flow, excluding legal and restructuring payments, was AUD 20.1 million, while overall cash flow was AUD 4.0 million. The company closed the period with a cash balance of AUD 40.0 million, up from AUD 38.0 million a year ago.

Nuix Neo Expansion

Nuix Neo was a major driver of growth in FY25. ACV from Nuix Neo increased by 132% to AUD 28.1 million, with customer numbers rising to 75, compared to 23 in the prior year. Sales growth was recorded across all three core Nuix Neo solutions – Data Privacy, Investigations, and Legal – while the newly introduced Nuix Neo Foundation also reported encouraging early adoption.

The company noted that customers migrating to Nuix Neo typically delivered an ACV uplift of 30–50%, while new Nuix Neo sales were 2–3 times larger than standard solution sales.

CEO Commentary

Chief Executive Officer Jonathan Rubinsztein stated that Nuix is increasingly focused on securing higher-value contracts and delivering further product innovation. He added that the restructuring of product and technology teams into a solutions-based model is expected to enhance scalability and execution speed in FY26.

Outlook

Looking ahead, Nuix outlined four key focus areas for FY26:

Sustained delivery of its business transformation strategy.
ACV growth led by Nuix Neo.
Revenue growth expected to outpace operating cost growth.
Maintaining positive underlying cash flow for the full year.

On the results announcement day, Nuix’s share price declined by 7.60% to trade at AUD 2.01 per share at the time of writing on 25 August 2025.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.